This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Statutory Instruments
Medicines
Made
13th September 2023
Coming into force
11th October 2023
The Secretary of State makes the following Regulations in exercise of the powers conferred by sections 2(1), 3(1)(j), (m) and (n) and 43(2) of the Medicines and Medical Devices Act 2021(1).
The Secretary of State has carried out a public consultation in accordance with section 45(1) of that Act.
In accordance with section 2(2) to (4) of that Act, the Secretary of State’s overarching objective in making these Regulations is safeguarding public health, the Secretary of State has had regard to the matters specified in section 2(3) of that Act and considers that, where these Regulations may have an impact on the safety of human medicines, the benefits of making these Regulations outweigh the risks.
In accordance with section 47(3) and (6)(a) of that Act, a draft of these Regulations was laid before Parliament and approved by a resolution of each House of Parliament.
2021 c. 3. The powers in section 2(1) of the Medicines and Medical Devices Act 2021, and in the provisions that relate to it, are exercisable by the “appropriate authority”. Section 2(6) of that Act contains the definition of “appropriate authority” that is relevant to the powers being exercised.
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
